0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis

Dennis Bourdette, MD1,2; Daniel Hartung, PharmD, MPH3
[+] Author Affiliations
1Department of Neurology, Oregon Health & Science University, Portland
2Multiple Sclerosis Center of Excellence West, Veterans Affairs Portland Health Care System, Portland, Oregon
3College of Pharmacy, Oregon State University/Oregon Health & Science University, Portland
JAMA Neurol. 2015;72(12):1411-1413. doi:10.1001/jamaneurol.2015.2605.
Text Size: A A A
Published online

Extract

Between 1993 and 2015, the US Food and Drug Administration (FDA) approved 13 drugs for the treatment of relapsing-remitting multiple sclerosis (MS). While these disease-modifying therapies (DMTs) fall into 7 different categories and vary in route of administration, adverse effects, and efficacy, they have one commonality—they are all very expensive, with acquisition costs exceeding $60 000 a year and continuing to escalate.1 One potential reason for the skyrocketing costs of MS DMTs is that they have never faced price competition from lower-cost generic drugs. The recent FDA approval of a generic version of branded glatiramer acetate (Copaxone; Teva Pharmaceuticals) signals the promise of true price competition among MS DMTs. However, the economic effect of the availability of a generic DMT is as yet unclear because this depends on the price of the generic and the extent of its use. Although pricing decisions are beyond our control, neurologists can have a large influence on how generic DMTs are used. As such, neurologists need to assess whether or not generic glatiramer acetate is equivalent to branded glatiramer acetate and acceptable for use in treating MS.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

736 Views
1 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
Jobs
brightcove.createExperiences();